Single center single arm clinical prospective study of neoantigen reactive T cells (NRTs) combined with PD-1 inhibitor in the treatment of Chinese patients with advanced refractory solid tumors

Trial Profile

Single center single arm clinical prospective study of neoantigen reactive T cells (NRTs) combined with PD-1 inhibitor in the treatment of Chinese patients with advanced refractory solid tumors

Suspended
Phase of Trial: Phase I/II

Latest Information Update: 01 Aug 2017

At a glance

  • Drugs INCSHR 1210 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions; Proof of concept; Therapeutic Use
  • Most Recent Events

    • 01 Aug 2017 Status changed from recruiting to suspended, according to an Incyte Corporation media release.
    • 02 Jun 2017 Status changed from not yet recruiting to recruiting.
    • 04 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top